So, MARCO-positive macrophages can be considered as a therapeutic target not only in proliferative diseases [45], but also in infectious diseases (viral and bacterial) and neurodegenerative diseases such as Alzheimer’s disease [46]. Here, MARCO is linked to early-onset autosomal dominant Alzheimer disease.